They can't just repeat the study. This is a phase 3 trial, large, long, and expensive. Also, regulators won't approve a repeat unless the company can justify it. If poor results then spray doesn't work and no point of repeating and if bottles were switched then low confidence in company and its CRO. Although very unlikely, I am hoping it was a switch, as unbelievably incompetent as it sounds.
- Forums
- ASX - By Stock
- Ann: Phase 3 Common Cold Trial Results
FRE
firebrick pharma limited
Add to My Watchlist
10.0%
!
7.7¢

They can't just repeat the study. This is a phase 3 trial,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.7¢ |
Change
0.007(10.0%) |
Mkt cap ! $17.50M |
Open | High | Low | Value | Volume |
7.5¢ | 7.7¢ | 7.5¢ | $5.56K | 73.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 32085 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 25500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32085 | 0.077 |
1 | 25000 | 0.067 |
3 | 407791 | 0.065 |
1 | 90000 | 0.063 |
2 | 191016 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 25500 | 1 |
0.091 | 948112 | 2 |
0.092 | 2476 | 1 |
0.099 | 100000 | 1 |
0.105 | 100000 | 1 |
Last trade - 15.57pm 25/07/2025 (20 minute delay) ? |
Featured News
FRE (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online